Publicaciones (16) Publicaciones de Aránzazu González Miqueo

2024

  1. A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function

    European Journal of Heart Failure, Vol. 26, Núm. 4, pp. 707-729

  2. Circulating biomarkers of myocardial remodelling: current developments and clinical applications

    Heart, Vol. 110, Núm. 19, pp. 1157-1163

  3. Effects of spironolactone on exercise blood pressure in patients at increased risk of developing heart failure: report from the HOMAGE trial

    Hypertension Research

  4. Myocardial Interstitial Fibrosis in Hypertensive Heart Disease: From Mechanisms to Clinical Management

    Hypertension, Vol. 81, Núm. 2, pp. 218-228

  5. Myocardial fibrosis from the perspective of the extracellular matrix: Mechanisms to clinical impact

    Matrix Biology, Vol. 134, pp. 1-22

  6. The fibroblast hormone Endotrophin is a biomarker of mortality in chronic diseases

    Matrix Biology, Vol. 132, pp. 1-9

  7. Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial

    Heart, Vol. 110, Núm. 19, pp. 1180-1187

2023

  1. Cardiac Fibrosis in heart failure: Focus on non-invasive diagnosis and emerging therapeutic strategies

    Molecular Aspects of Medicine, Vol. 93

  2. Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study

    Circulation: Heart Failure, Vol. 16, Núm. 5, pp. E009694

2022

  1. Generation of NKX2.5GFP Reporter Human iPSCs and Differentiation Into Functional Cardiac Fibroblasts

    Frontiers in Cell and Developmental Biology, Vol. 9

2021

  1. A novel treatment for heart failure targets myocardial fibrosis

    Nature Medicine, Vol. 27, Núm. 8, pp. 1343-1344

  2. Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches

    Nature Reviews Cardiology, Vol. 18, Núm. 7, pp. 479-498

2020

  1. Microvascular and lymphatic dysfunction in HFpEF and its associated comorbidities

    Basic Research in Cardiology, Vol. 115, Núm. 4

2019

  1. Characterization of biventricular alterations in myocardial (reverse) remodelling in aortic banding-induced chronic pressure overload

    Scientific Reports, Vol. 9, Núm. 1

2005

  1. Avances en el diagnóstico de la cardiopatía hipertensiva

    Hipertensión y riesgo vascular, Vol. 22, Núm. 6, pp. 259-265

2001

  1. Marcadores bioquímicos de fibrosis miocárdica en las enfermedades cardíacas

    Hipertensión y Riesgo Vascular, Vol. 18, Núm. 8, pp. 383-388